Latest News From RBM

The Roll Back Malaria (RBM) Partnership has named a new board to lead the global organization into a new era and drive momentum to end malaria for good.

The intensified, collaborative effort by RBM partners to support affected countries to end malaria is saving millions of lives, increasing attendance at school, improving worker productivity and boosting local economies. But malaria remains a serious public health threat. Eliminating malaria is critical to achieving the Sustainable Development Goals, and must remain a key priority for the global development community.

In the middle of December 2013, the RBM Board commissioned an external evaluation to ensure the Partnership was well positioned to drive continued momentum towards a malaria-free world This evaluation concluded that significant adjustments to RBM’s structure would be necessary to sustain its successes and build on them to deliver on the ambitious goals and objectives of the 2030 WHO Global Technical Strategy (GTS) and accompanying RBM Action and Investment to defeat Malaria (AIM).

After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era with a focus on ending malaria. As a result, a transparent public nomination process was announced in January 2016 to identify outstanding new Board members.

The response to the call for nominations was overwhelming: more than 100 nominations were received from the wide malaria and related multi-sectoral community, including government, civil society, non-government organisations, the private sector, donor funding organisations (governmental, multilateral or private philanthropic), and research and academia.

After a robust assessment and selection process 13 individuals have been chosen to take the revitalised Partnership forward, along with an additional Board member to be named by the WHO:

  • Mr Elhadj As Sy, Secretary General, International Federation of Red Cross and Red Crescent Societies
  • Mr Simon Bland, Director – New York Office, UNAIDS
  • Prof Awa Coll-Seck, Minister of Health & Social Welfare, Senegal
  • Mr Kieran Daly, Deputy Director: Global Policy & Advocacy – Malaria, HIV, TB and the Global Fund, Bill & Melinda Gates Foundation
  • Mr Paolo Gomes, Chairman, Paulo Gomes and Partners, former Executive Director, World Bank
  • Dr Richard Nchabi Kamwi, Elimination 8 Ambassador, former Minister of Health, Namibia
  • Dr Altaf Lal, Senior Advisor on Global Health and Innovation, Sun Pharmaceuticals Industries
  • Dr Winnie Mpanju-Shumbusho, former Assistant Director General - Malaria, HIV, TB, NTDs, WHO
  • Mr Ray Nishimoto, President of Health & Crop Sciences Sector, Sumitomo Chemical
  • Dr David Reddy, Chief Executive, Medicines for Malaria Venture
  • Mr Gu Xueming, President of the Chinese Academy of International Trade and Economic Cooperation
  • HE Yongyuth Yuthavong, Deputy Prime Minister, Thailand
  • Rear Admiral Tim Ziemer USN (ret), Global Co-ordinator, US President's Malaria Initiative

This new Partnership Board includes individuals with deep expertise and experience at a senior decision-making level as well as representation from across the Partnership, including malaria-affected countries, private sector, civil society, donor funding organisations, and entities outside the malaria and health sectors, civil society and donors.

In confirming the result of the vote the current Board Chair the Honorable Victor Makwenge Kaput stated that he believed that the individuals selected:

“represented an impressive group of distinctly qualified individuals who will be well-positioned to take the RBM Partnership to a new level in its evolution.”

The new Board are expected to assume responsibility for leading the Partnership from April 2016 and RBM are confident that the changes to the architecture of the Partnership will result in a strengthened malaria partnership well-positioned to support the delivery of the ambitious goal of Ending Malaria for Good.

After a two-year period of broad consultation and discussion, the RBM Board decided to establish a new, more robust structure that takes advantage of the tremendous skill, energy and effectiveness of its many partners and to move conclusively into a new era that will take action to realize the vision of a world free of malaria.

As part of this new structure, RBM Board decided to launch a process for the establishment of a new Partnership Board. The nominations process for new Board members is now open. Nominations will close on 5 February 2016. The links below provide full details of the nominations process and the related forms for nominating candidates for the new Partnership Board.

[Board Nomination form]
[Board Nomination pack]

Since 1998, the Roll Back Malaria Partnership (RBM) – hosted by the World Health Organization (WHO) – has been central to the global fight against malaria. The past fifteen years have seen tremendous gains in reducing the burden of disease and progressing towards malaria elimination. According to the World Malaria Report 2015, released on 9 December 2015, more than half (57) of the 106 countries with malaria in 2000 had achieved reductions in new malaria cases of at least 75% by 2015. In that same time frame, 18 countries reduced their malaria cases by 50-75%.

The success of the RBM Partnership in harmonizing partner action against malaria has enabled us to set an even more ambitious target for the next 15 years: with the WHO Global Technical Strategy (GTS) and accompanying RBM Action and Investment to defeat Malaria (AIM) setting our collective sights on a further 90% reduction by 2030; and the Global Goals for Sustainable Development under Target 3.3 calling on partners to "end" malaria. The expected cost to achieve these goals is currently estimated at ~$100 Billion, setting us an equally ambitious resource mobilization challenge to meet these targets.

Every four to five years, RBM has commissioned an External Evaluation to ensure the Partnership remains fit-for-purpose to drive continued momentum towards a malaria-free world. The most recent evaluation in December 2013 highlighted that significant adjustments to RBM’s structure would be necessary to sustain its successes and build on them to deliver on the GTS’ ambitious 2030 goals and objectives. The External evaluation noted that the Partnership must be better able to support malaria-affected regions and countries with a high burden of disease, and adapt to overcome the significant barriers to realizing the targets in the GTS.

The report also noted that the changing malaria landscape and political environment would require the Partnership to be better equipped to advocate for financing at the highest levels in the increasingly complex world of international development and global health finance. The RBM partnership needs to marshal the international community and build the necessary national contributions and capacity to mobilize the necessary resources to achieve malaria elimination.

After a considerable period of consultation, and with the end of the hosting relationship with WHO, RBM is ready to take forward a new structure that takes advantage of the tremendous skill, energy and effectiveness of its many partners and will move it conclusively into a new era that aims to have a world free of malaria.

To make the revitalized Partnership fit-for-purpose, the RBM Board agreed at its 29th Meeting on a new governance architecture. This will include the establishment of a reconstituted Partnership Board to lead it, planned to be in place by March 2016. The nomination process for the new Partnership Board will be open from 9 January 2016 and 5 February 2016.

This Partnership Board will be selected to contain enhanced levels of skills and experience at a senior decision-making level as well as representation from across the Partnership, including malaria-affected countries, private sector, civil society, donor funding organisations, and entities outside the malaria and health sectors, civil society and donors.

Priorities for the new Partnership Board will include examination of alternatives for hosting for the RBM Partnership, recruiting a CEO, establishing the new partnership structures, and assessing and instituting new country and regional structures.

As we move into the new era of the RBM Partnership, we recognize how far we have already come in the fight against malaria, and the immense contributions of the Partnership and the outgoing RBM Secretariat. We are confident that the changes to the RBM Partnership architecture will result in a strengthened malaria partnership well-positioned to support the delivery of the ambitious goal of a malaria-free world.

Transition Support
A new Transition Support Team has been convened by Malaria No More UK in November 2015, to provide additional project management support to the Transition Oversight Committee. They will act as a central point of contact for the Transition over the coming months, providing Transition Management Support to the TOC and, if required, in transitioning to the incoming Board.

This small Transition Support Team is comprised of targeted programme and change management experts, led by Jonah Grunsell from Headadvisory Consulting based in the UK. They have extensive experience in leading transformational change programmes in the public and third sectors. Ian Boulton (TropMed Pharma Consulting) will also bring his insight and expertise from fifteen years of involvement with the fight against malaria and RBM to the team. They can be contacted at ProgTeam@RBMTransition.com.

The Restructuring Q&A has not been fully updated, but further information on the Restructuring Process is now available here.